Previous studies have reported that PTTG1 is associated with aggressive disease and poor prognosis in a variety of malignant tumors, including HCC.20, 28, 43 In this regard, we further examined the influence of PTTG1 overexpression on HCC patients’ clinical outcomes. This evidence concerns the gene PTTG1 and hepatocellular carcinoma.